Title : Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.

Pub. Date : 1999 Apr

PMID : 10200742






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: The goal of this placebo-controlled study was to evaluate the efficacy and safety of low doses of amisulpride, an atypical antipsychotic of the benzamide class with high affinity for D2 and D3 dopamine receptors, in the treatment of schizophrenic patients with predominantly primary negative symptoms. Amisulpride dopamine receptor D2 Homo sapiens